Language:
Daily summary of financings for therapeutic biotechnology company executives and investors
Thursday, December 11, 2025
Terns’s $748Million Public Offering
Dyne’s $403 Million Public Offering
Enveric’s $3 Million Warrant Exercise
Wednesday, December 10, 2025
BlossomHill’s $84 million Series B
PsiThera’s $48 Million Series A…More
EpilepsyGTx’s $33 Million Series A
Allonia’s $20 Million Series A
Moleculin’s $7 Million Warrant Exercise
Bioxodes’s $6 Million Series A
Tuesday, December 9, 2025
Kymera’s $602 Million Public Offering
Immix’s $100 Million Public Offering
EpilepsyGTx’s $33 Million Series A
TuHURA’s $16 Million Registered Direct Offering
Aprea’s $3 Million Private Placement
Monday, December 8, 2025
Structure’s $500 Million Public Offering
Wave Life Sciences’ $250 Million Public Offering
Vera’s $200 Million Public Offering
Fulcrum’s $150 Million Public Offering
Convergen’s $10 Million Seed Round
Sunday, December 7, 2025
Immix’s $100 Million Public Offering
Friday, December 5, 2025
Capricor’s $150 Million Public Offering
Immatics’s $125 Million Public Offering
Medicus’s $5 Million Warrant Exercise
Thursday, December 4, 2025
Denali’s $275 Million Royalty Financing
Crescent’s $185 Million Private Placement
Protara’s $75 Million Public Offering
SciNeuro’s $53 Million Equity Investment
KALA’s $10 Million Registered Direct Offering
Wednesday, December 3, 2025
Auxilius’s $4 Million Series A
Tuesday, December 2, 2025
Belite’s $350 Million Public Offering
Pasithea’s $60 Million Public Offering
Kazia’s $50 Million Private Placement
Axoltis’s $21 Million Series A
Monday, December 1, 2025
Protego’s $130 Million Series B
Circular’s $15 Million Series A
Wednesday, November 26, 2025
Cormorant’s $400 Million Fund Raise
Tempest’s $8 Million Registered Direct Offering
Adial’s $3 Million Warrant Exercise
Tuesday, November 25, 2025
Phrontline’s $60 Million Pre-A+
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck